HMOX1 and infarction: The rat model of MI we adopted in the present study manifested large infarct size but relatively low mortality (36% of LV and 25% respectively at 4 weeks), thus allowing the study of the long-term efficacy of HO-1 activation many hours after MI initiation on both mortality and LV remodeling in survivors.